| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 14 | 2020 | 246 | 2.680 |
Why?
|
| Sea Lions | 4 | 2019 | 8 | 1.880 |
Why?
|
| Podocytes | 8 | 2019 | 113 | 1.420 |
Why?
|
| Kidney Glomerulus | 5 | 2017 | 155 | 1.330 |
Why?
|
| Kainic Acid | 3 | 2015 | 44 | 1.140 |
Why?
|
| Kidney | 9 | 2019 | 945 | 0.980 |
Why?
|
| Angiotensin I | 4 | 2014 | 24 | 0.940 |
Why?
|
| Neprilysin | 5 | 2018 | 55 | 0.910 |
Why?
|
| Diatoms | 4 | 2017 | 7 | 0.870 |
Why?
|
| Renin-Angiotensin System | 4 | 2013 | 79 | 0.810 |
Why?
|
| Medicine | 1 | 2022 | 52 | 0.810 |
Why?
|
| Nephrology | 1 | 2022 | 43 | 0.800 |
Why?
|
| Glutamyl Aminopeptidase | 4 | 2017 | 12 | 0.760 |
Why?
|
| Students, Medical | 1 | 2022 | 210 | 0.690 |
Why?
|
| Leptospira interrogans | 1 | 2018 | 1 | 0.650 |
Why?
|
| Leptospirosis | 1 | 2018 | 2 | 0.650 |
Why?
|
| Angiotensin II | 4 | 2014 | 220 | 0.640 |
Why?
|
| Resistin | 1 | 2018 | 9 | 0.640 |
Why?
|
| Neuromuscular Depolarizing Agents | 2 | 2015 | 12 | 0.620 |
Why?
|
| Acclimatization | 3 | 2017 | 14 | 0.610 |
Why?
|
| Kidney Diseases | 2 | 2019 | 307 | 0.600 |
Why?
|
| Peptide Fragments | 5 | 2014 | 483 | 0.550 |
Why?
|
| Sulfonium Compounds | 2 | 2012 | 2 | 0.510 |
Why?
|
| Animals | 28 | 2021 | 20881 | 0.500 |
Why?
|
| Acute Kidney Injury | 6 | 2013 | 232 | 0.490 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 92 | 0.490 |
Why?
|
| Membrane Proteins | 2 | 2017 | 617 | 0.490 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2012 | 38 | 0.480 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 102 | 0.480 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 507 | 0.460 |
Why?
|
| Biomarkers | 11 | 2020 | 1593 | 0.380 |
Why?
|
| Oxazolidinones | 1 | 2010 | 6 | 0.360 |
Why?
|
| Acidosis, Lactic | 1 | 2010 | 6 | 0.360 |
Why?
|
| Acetamides | 1 | 2010 | 17 | 0.360 |
Why?
|
| Angiotensinogen | 3 | 2013 | 18 | 0.330 |
Why?
|
| Shiitake Mushrooms | 1 | 2008 | 1 | 0.330 |
Why?
|
| Flammulina | 1 | 2008 | 1 | 0.330 |
Why?
|
| Endothelial Cells | 1 | 2012 | 384 | 0.320 |
Why?
|
| Fungal Proteins | 1 | 2008 | 37 | 0.320 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 6 | 2011 | 50 | 0.320 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 166 | 0.310 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2019 | 43 | 0.280 |
Why?
|
| Ice | 2 | 2021 | 13 | 0.270 |
Why?
|
| Urine | 1 | 2006 | 47 | 0.270 |
Why?
|
| Mice | 11 | 2019 | 8474 | 0.260 |
Why?
|
| Sodium Chloride | 1 | 2006 | 136 | 0.260 |
Why?
|
| Membrane Transport Proteins | 1 | 2006 | 81 | 0.260 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2014 | 306 | 0.250 |
Why?
|
| Glomerulonephritis | 2 | 2019 | 77 | 0.240 |
Why?
|
| Male | 21 | 2020 | 37321 | 0.240 |
Why?
|
| Humans | 28 | 2022 | 68618 | 0.220 |
Why?
|
| Models, Biological | 3 | 2021 | 981 | 0.220 |
Why?
|
| Cryoprotective Agents | 1 | 2003 | 31 | 0.220 |
Why?
|
| Proteome | 2 | 2021 | 87 | 0.210 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 498 | 0.210 |
Why?
|
| Urinalysis | 3 | 2018 | 27 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2019 | 1692 | 0.200 |
Why?
|
| Oceans and Seas | 2 | 2019 | 10 | 0.200 |
Why?
|
| Career Choice | 1 | 2022 | 98 | 0.190 |
Why?
|
| Chiroptera | 1 | 2021 | 1 | 0.190 |
Why?
|
| Cells, Cultured | 5 | 2019 | 2673 | 0.190 |
Why?
|
| Nostoc | 1 | 2021 | 1 | 0.190 |
Why?
|
| Cilia | 2 | 2019 | 94 | 0.180 |
Why?
|
| Renin | 2 | 2013 | 96 | 0.180 |
Why?
|
| Complement C7 | 1 | 2020 | 1 | 0.180 |
Why?
|
| Rats | 6 | 2017 | 5300 | 0.180 |
Why?
|
| Exocytosis | 1 | 2019 | 34 | 0.170 |
Why?
|
| Extracellular Vesicles | 1 | 2019 | 21 | 0.170 |
Why?
|
| Formoterol Fumarate | 1 | 2019 | 25 | 0.170 |
Why?
|
| Water Microbiology | 1 | 2019 | 24 | 0.170 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2019 | 18 | 0.160 |
Why?
|
| Myosin Type I | 1 | 2019 | 20 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 87 | 0.160 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 27 | 0.160 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 87 | 0.160 |
Why?
|
| Kidney Tubules, Collecting | 2 | 2011 | 46 | 0.160 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 245 | 0.160 |
Why?
|
| Cell Line | 5 | 2019 | 1752 | 0.160 |
Why?
|
| Osteopontin | 1 | 2018 | 28 | 0.160 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 30 | 0.160 |
Why?
|
| Predictive Value of Tests | 7 | 2020 | 1465 | 0.160 |
Why?
|
| Lipocalin-2 | 1 | 2018 | 19 | 0.160 |
Why?
|
| Biological Assay | 1 | 2019 | 88 | 0.160 |
Why?
|
| Muramidase | 1 | 2018 | 38 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2019 | 2689 | 0.160 |
Why?
|
| Peptides | 2 | 2014 | 455 | 0.150 |
Why?
|
| Isodesmosine | 1 | 2017 | 6 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2019 | 113 | 0.150 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 25 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 2021 | 597 | 0.150 |
Why?
|
| Proteins | 2 | 2011 | 474 | 0.140 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 1083 | 0.140 |
Why?
|
| Cold Temperature | 1 | 2017 | 90 | 0.140 |
Why?
|
| Genome | 1 | 2017 | 54 | 0.140 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 1447 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 301 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 79 | 0.140 |
Why?
|
| Ice Cover | 2 | 2017 | 2 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 384 | 0.140 |
Why?
|
| Mass Spectrometry | 4 | 2013 | 284 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.130 |
Why?
|
| Genomics | 1 | 2017 | 168 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 770 | 0.130 |
Why?
|
| Cross Reactions | 1 | 2015 | 57 | 0.130 |
Why?
|
| Bronchial Fistula | 1 | 2015 | 5 | 0.130 |
Why?
|
| Female | 13 | 2020 | 38074 | 0.130 |
Why?
|
| Antibody Specificity | 1 | 2015 | 98 | 0.130 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 16 | 0.130 |
Why?
|
| Albumins | 1 | 2015 | 72 | 0.130 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2015 | 16 | 0.130 |
Why?
|
| Support Vector Machine | 1 | 2015 | 15 | 0.130 |
Why?
|
| Eosinophils | 1 | 2015 | 60 | 0.120 |
Why?
|
| Arrestins | 2 | 2013 | 92 | 0.120 |
Why?
|
| Lupus Nephritis | 1 | 2016 | 193 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 643 | 0.120 |
Why?
|
| Marine Toxins | 1 | 2014 | 14 | 0.120 |
Why?
|
| Neuromuscular Junction | 1 | 2014 | 15 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2800 | 0.120 |
Why?
|
| Interleukin-18 | 1 | 2013 | 16 | 0.110 |
Why?
|
| Radiation-Protective Agents | 1 | 2013 | 16 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1293 | 0.110 |
Why?
|
| Thioredoxins | 1 | 2013 | 26 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2011 | 246 | 0.110 |
Why?
|
| Machine Learning | 1 | 2015 | 170 | 0.110 |
Why?
|
| Haptoglobins | 1 | 2013 | 12 | 0.110 |
Why?
|
| Teriparatide | 1 | 2013 | 7 | 0.110 |
Why?
|
| Angiotensins | 1 | 2013 | 16 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2013 | 168 | 0.110 |
Why?
|
| Databases, Protein | 2 | 2019 | 49 | 0.110 |
Why?
|
| Isethionic Acid | 1 | 2012 | 1 | 0.110 |
Why?
|
| Betaine | 1 | 2012 | 3 | 0.110 |
Why?
|
| Picolinic Acids | 1 | 2012 | 4 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 65 | 0.100 |
Why?
|
| Proline | 1 | 2012 | 52 | 0.100 |
Why?
|
| Carboxypeptidases | 1 | 2012 | 8 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2013 | 450 | 0.100 |
Why?
|
| Parathyroid Hormone | 1 | 2013 | 117 | 0.100 |
Why?
|
| Phytoplankton | 1 | 2011 | 1 | 0.100 |
Why?
|
| Photosystem II Protein Complex | 1 | 2011 | 1 | 0.100 |
Why?
|
| Photosynthesis | 1 | 2011 | 3 | 0.100 |
Why?
|
| Adenosylhomocysteinase | 1 | 2011 | 2 | 0.100 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2011 | 2 | 0.100 |
Why?
|
| S-Adenosylmethionine | 1 | 2011 | 9 | 0.100 |
Why?
|
| Methyltransferases | 1 | 2011 | 19 | 0.100 |
Why?
|
| Salinity | 1 | 2011 | 8 | 0.100 |
Why?
|
| Methionine | 1 | 2011 | 36 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 161 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 202 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2013 | 152 | 0.100 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2011 | 3 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2008 | 165 | 0.100 |
Why?
|
| Chromatography, Liquid | 2 | 2013 | 120 | 0.100 |
Why?
|
| Child | 1 | 2022 | 6405 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2011 | 27 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 245 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 80 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 370 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2013 | 344 | 0.090 |
Why?
|
| Freezing | 2 | 2017 | 29 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 107 | 0.090 |
Why?
|
| Azotemia | 1 | 2010 | 2 | 0.090 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 4 | 0.090 |
Why?
|
| Linezolid | 1 | 2010 | 7 | 0.090 |
Why?
|
| ROC Curve | 3 | 2019 | 392 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2012 | 204 | 0.090 |
Why?
|
| Prognosis | 5 | 2013 | 2093 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 231 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 292 | 0.090 |
Why?
|
| Genes, Fungal | 1 | 2008 | 24 | 0.080 |
Why?
|
| Tropomyosin | 1 | 2008 | 4 | 0.080 |
Why?
|
| Lamin Type A | 1 | 2008 | 9 | 0.080 |
Why?
|
| Vimentin | 1 | 2008 | 47 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 231 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2011 | 431 | 0.080 |
Why?
|
| Vitamin D | 1 | 2012 | 516 | 0.080 |
Why?
|
| Doxorubicin | 2 | 2019 | 231 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 1851 | 0.070 |
Why?
|
| CD13 Antigens | 1 | 2007 | 5 | 0.070 |
Why?
|
| Loop of Henle | 1 | 2006 | 6 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 76 | 0.070 |
Why?
|
| Nephrolithiasis | 1 | 2006 | 9 | 0.070 |
Why?
|
| Kidney Tubules, Distal | 1 | 2006 | 15 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 2006 | 19 | 0.070 |
Why?
|
| Mesangial Cells | 1 | 2007 | 37 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 615 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 742 | 0.070 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2006 | 81 | 0.070 |
Why?
|
| Atlantic Ocean | 1 | 2006 | 22 | 0.070 |
Why?
|
| Seawater | 1 | 2006 | 29 | 0.070 |
Why?
|
| Proteinuria | 1 | 2006 | 136 | 0.070 |
Why?
|
| Osmolar Concentration | 1 | 2006 | 134 | 0.070 |
Why?
|
| Fresh Water | 1 | 2006 | 43 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2012 | 756 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 181 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2006 | 114 | 0.070 |
Why?
|
| Cell Survival | 2 | 2013 | 901 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2006 | 174 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 357 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2015 | 7277 | 0.060 |
Why?
|
| Disease Progression | 3 | 2013 | 1038 | 0.060 |
Why?
|
| Hemocytes | 1 | 2005 | 2 | 0.060 |
Why?
|
| Vibrio Infections | 1 | 2005 | 3 | 0.060 |
Why?
|
| Myocardium | 2 | 2014 | 1204 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 206 | 0.060 |
Why?
|
| Hypertension | 1 | 2014 | 1535 | 0.060 |
Why?
|
| Adult | 5 | 2020 | 21403 | 0.060 |
Why?
|
| Penaeidae | 1 | 2005 | 16 | 0.060 |
Why?
|
| Logistic Models | 3 | 2013 | 1420 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2006 | 141 | 0.060 |
Why?
|
| Aged | 6 | 2020 | 14862 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2550 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 2 | 2017 | 274 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 2083 | 0.060 |
Why?
|
| Middle Aged | 7 | 2020 | 21147 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1085 | 0.060 |
Why?
|
| Serum Albumin, Bovine | 1 | 2003 | 43 | 0.050 |
Why?
|
| Elasmobranchii | 1 | 2003 | 9 | 0.050 |
Why?
|
| Risk Factors | 4 | 2013 | 5731 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2013 | 238 | 0.050 |
Why?
|
| Thromboxane B2 | 1 | 2003 | 108 | 0.050 |
Why?
|
| Thromboxane A2 | 1 | 2003 | 88 | 0.050 |
Why?
|
| Creatinine | 2 | 2013 | 243 | 0.050 |
Why?
|
| beta-Arrestins | 2 | 2013 | 80 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 546 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2014 | 326 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 1140 | 0.050 |
Why?
|
| Aorta | 1 | 2003 | 316 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2013 | 1174 | 0.050 |
Why?
|
| Antarctic Regions | 1 | 2021 | 5 | 0.050 |
Why?
|
| Metagenome | 1 | 2021 | 17 | 0.050 |
Why?
|
| Species Specificity | 1 | 2021 | 303 | 0.050 |
Why?
|
| alpha-Macroglobulins | 1 | 2020 | 8 | 0.040 |
Why?
|
| Complement C8 | 1 | 2020 | 4 | 0.040 |
Why?
|
| Time Factors | 3 | 2013 | 4655 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2019 | 22 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1745 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2013 | 108 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 114 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 11 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 51 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 34 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2019 | 34 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 2077 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 58 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 1026 | 0.040 |
Why?
|
| Luciferases | 1 | 2019 | 105 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 46 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 490 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 191 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 88 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2014 | 753 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2011 | 1200 | 0.040 |
Why?
|
| Serpins | 1 | 2020 | 205 | 0.040 |
Why?
|
| Algorithms | 2 | 2016 | 1196 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 214 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 78 | 0.040 |
Why?
|
| Genetic Drift | 1 | 2017 | 4 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2017 | 11 | 0.040 |
Why?
|
| Darkness | 1 | 2017 | 27 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 371 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 562 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 62 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 78 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 2791 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 187 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 948 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 197 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 386 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1342 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 365 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2015 | 19 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 164 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 47 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 2015 | 66 | 0.030 |
Why?
|
| Iron | 1 | 2017 | 197 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2014 | 109 | 0.030 |
Why?
|
| Normal Distribution | 1 | 2014 | 46 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1664 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1027 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 215 | 0.030 |
Why?
|
| Mitochondrial Swelling | 1 | 2014 | 10 | 0.030 |
Why?
|
| Vacuoles | 1 | 2014 | 10 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 652 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2014 | 103 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2014 | 216 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 2014 | 24 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 4848 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 181 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 127 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2013 | 10 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2010 | 738 | 0.030 |
Why?
|
| Mice, Congenic | 1 | 2013 | 13 | 0.030 |
Why?
|
| Benzylamines | 1 | 2013 | 28 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2013 | 20 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2013 | 78 | 0.030 |
Why?
|
| Extracellular Fluid | 1 | 2013 | 29 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 114 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2013 | 24 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 567 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 37 | 0.030 |
Why?
|
| Systems Biology | 1 | 2013 | 25 | 0.030 |
Why?
|
| Bone Development | 1 | 2013 | 37 | 0.030 |
Why?
|
| Cold Climate | 1 | 2012 | 2 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 217 | 0.030 |
Why?
|
| Metabolome | 1 | 2012 | 15 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 55 | 0.030 |
Why?
|
| Metabolomics | 1 | 2012 | 28 | 0.030 |
Why?
|
| Albuminuria | 1 | 2013 | 171 | 0.030 |
Why?
|
| Culture Media | 1 | 2012 | 155 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1641 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2013 | 145 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2013 | 99 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 536 | 0.030 |
Why?
|
| Bone Density | 1 | 2013 | 159 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 268 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2013 | 384 | 0.020 |
Why?
|
| Histone Chaperones | 1 | 2011 | 11 | 0.020 |
Why?
|
| beta-Arrestin 1 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2011 | 29 | 0.020 |
Why?
|
| beta-Arrestin 2 | 1 | 2011 | 29 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 563 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 167 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 57 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 64 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 448 | 0.020 |
Why?
|
| United States | 2 | 2013 | 7367 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 839 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 682 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 346 | 0.020 |
Why?
|
| Rotation | 1 | 2011 | 58 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 67 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2013 | 307 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 880 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 150 | 0.020 |
Why?
|
| Hippocampus | 1 | 2014 | 471 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 147 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2010 | 12 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2011 | 110 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 175 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 630 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2010 | 104 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2011 | 270 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 194 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 32 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2008 | 35 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 1118 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 331 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1033 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 371 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2007 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1034 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 2279 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 12 | 0.020 |
Why?
|
| Shellfish | 1 | 2005 | 8 | 0.020 |
Why?
|
| Vibrio | 1 | 2005 | 14 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 95 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 7029 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 710 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 73 | 0.010 |
Why?
|
| Receptors, Thromboxane | 1 | 2003 | 122 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 117 | 0.010 |
Why?
|
| Indomethacin | 1 | 2003 | 107 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2003 | 210 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 765 | 0.010 |
Why?
|